Chronic Non-malignant Pain Management Best Practice per Tennessee Guidelines and Federal REMs: an Interprofessional Perspective

NOTE: When you are ready to begin the CME activity, please scroll to the bottom of the page - login/register and "add to cart." It is recommended to download the presentation and case slides from the below attached pdf files to use for notes. 

The course includes:

1. Pre-test
2. Video
3. Post-test
4. Course evaluation
5. Certificate

Background

Public Chapter 430 of the State of Tennessee and the Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic non-Malignant Pain defines appropriate measures and requirements for all practitioners who prescribe controlled substances to complete two hours of continuing education relevant to controlled drug prescribing. 

Additionally, in July 2012, the FDA approved a risk evaluation and mitigation strategy (REMS) for extended-release (ER) and long-acting (LA opioid medication. The REMS is part of a multi-agency Federal effort to address the growing problem of prescription drug abuse and misuse.

This two-hour, interprofessional panel, educational activity combines the Tennessee guidelines and REMS goals to increase understanding of appropriate patient assessment and prescribing practices among Tennessee and other health care professionals to help reduce misuse, abuse, and overdose deaths associated with ER/LA opioid analgesics.

Course Instructions

Participants will need to complete the post-test (70% pass rate) and program evaluation to receive CME credit. Once the requirements are successfully completed, a certificate can be downloaded. The program can be completed at participant's convenience.

A Certificate of Completion is provided after the completion of required activities (post-test and evaluation) for health care professionals who want to self-claim Continuing Education (CE) credit.

AOA and AMA PRA CME for this activity will automatically be submitted to the appropriate accrediting body.

The online course will include an Outcomes Measure assessment immediately after the activity and as an optional 90-day assessment. Participants can obtain one additional Category 1-B Credit for completion of the 90-day outcomes assessment

Course Format and Fees

This educational activity is presented in an online, recorded panel presentation and powerpoint slide format. 

Cost:  $40

LMU clinical faculty - $20 (applied at the cart level)
LMU-DCOM alumni - $10 (applied at the cart level)

Residents - $10 (applied at the cart level)

Review Date: November 4, 2015

Original Release Date: December 14, 2015

Termination Date: December 14, 2017

Course Prerequisites  No course prerequisites

Estimated Time to Complete: 2 hours (can be completed at your convenience)

Click here for planning committee, speakers and financial disclosures

Accreditation and Designation Statements

Click here for Accreditation and Designation Statements

Disclosure Statement

Click here for LMU-DCOM Policy on Privacy and Confidentiality for Internet CME

 

Course details

  • AMA PRA Category 1 CreditTM: 2.00
  • AOA CME Credit: 2.00
  • Attendance: 2.00
  • Course opens: Mon, Dec 14 2015
  • Course expires: Thu, Dec 14 2017
  • Cost: $40.00

Target audience

Primary: Prescribers, of at least one ER/LA opioid prescription in the past year, in the State of Tennessee including, physicians, physician assistants, nurse practitioners, and veterinarians, who need to meet state prescribing requirements.

Physicians (MDs and DOs) 
PAs 
Nurse practitioners 
Veterinarians 
Dentist
 

Secondary: other health care providers interested in understanding prescribing requirements.  

Psychologists
Social workers 
Addiction Specialists 
Pharmacists 

 

 

Learning objectives

At the end of the presentation, participants will be able to:
 
1.  Identify key principles of Tennessee Clinical Practice Guidelines for the Management of Chronic Pain and the FDA blueprint for  
     risk evaluation and mitigation strategies related to long acting opioids.
2.  Appropriately assess patients for opioid treatment, including long-acting or extended release formulations.
3.  Apply best practices during initiation of therapy, dose modification, and discontinuation of opioids, including long-acting or
     extended release formulations.
4.  Appropriately counsel patients about their pain management regimens, including long-acting or extended release opioid
     formulations.
5.  Relate basic pharmacodynamics, pharmacokinetics, and toxicology of opioids to role in treatment, abuse potential, and laboratory
     test interpretation.
6.  Compare and contrast currently available long-acting and extended release opioid formulations, including review of selected
     product-specific drug information. 
 

 

 

 

Faculty & credentials

Mary Beth Babos, RPh, BS Pharm, PharmD, CDE
Associate Professor of Pharmacy
Lincoln Memorial University-DeBusk College of Osteopathic Medicine

Sharon N. Duke, DO, PhD, DABAM
Addiction Medicine, East Tennessee Pathways

Stephanie Hamil, LCSW
Executive Director, Friends of Hospice of the Lakeway Area

Dwan Perry, DO
Assistant Professor of Physical Medicine and Rehabilitation/Sports Medicine
Lincoln Memorial University-DeBusk College of Osteopathic Medicine

Howard Teitelbaum, DO, PhD, MPH
Professor and Chair of Preventive Medicine
Lincoln Memorial University-DeBusk College of Osteopathic Medicine

Elizabeth Burchette Thompson, DVM
Assistant Professor of Veterinary Science and Dean, School of Allied Health Sciences
Lincoln Memorial University

Byron Turkett, MPAS, PA-C, FCCM
Assistant Professor, Clinical and Didactic Services
Lincoln Memorial University-DeBusk College of Osteopathic Medicine

 

 

 

Please log in or register to take this Course.